ArticlePharmacoEconomics2020

Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome.

Michael Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.